Demethylation of the TSDR Is a Marker of Squamous Cell Carcinoma in Transplant Recipients

Hariharan, 2000, Improved graft survival after renal transplantation in the United States, 1988 to 1996, N Engl J Med, 342, 605, 10.1056/NEJM200003023420901 Lodhi, 2011, Solid organ allograft survival improvement in the United States: The long-term does not mirror the dramatic short-term success, Am J Transplant, 11, 1226, 10.1111/j.1600-6143.2011.03539.x Olyaei, 2005, Cardiovascular complications of immunosuppressive agents in renal transplant recipients, Expert Opin Drug Saf, 4, 29, 10.1517/14740338.4.1.29 Fishman, 2009, Introduction: Infection in solid organ transplant recipients, Am J Transplant, 9, S3, 10.1111/j.1600-6143.2009.02887.x Bottomley, 2013, Update on the long-term compications of transplantation, Br Med Bull, 106, 117, 10.1093/bmb/ldt012 Chang, 2007, Trends in kidney transplantation in Australia and New Zealand, 1993–2004, Transplantation, 84, 611, 10.1097/01.tp.0000280553.23898.ef Collett, 2010, Comparison of the incidence of malignancy in recipients of different types of organ: A UK registry audit, Am J Transplant, 10, 1889, 10.1111/j.1600-6143.2010.03181.x Kasiske, 2004, Cancer after kidney transplantation in the United States, Am J Transplant, 4, 905, 10.1111/j.1600-6143.2004.00450.x Engels, 2011, Spectrum of cancer risk among US solid organ transplant recipients, JAMA, 306, 1891, 10.1001/jama.2011.1592 Vajdic, 2006, Cancer incidence before and after kidney transplantation, JAMA, 296, 2823, 10.1001/jama.296.23.2823 Carroll, 2010, Immune phenotype predicts risk for posttransplantation squamous cell carcinoma, J Am Soc Nephrol, 21, 713, 10.1681/ASN.2009060669 Veness, 1999, Aggressive cutaneous malignancies following cardiothoracic transplantation: The Australian experience, Cancer, 85, 1758, 10.1002/(SICI)1097-0142(19990415)85:8<1758::AID-CNCR16>3.0.CO;2-F Thibaudin, 2005, Long-term kinetic of T-lymphocyte subsets in kidney-transplant recipients: Influence of anti-T-cell antibodies and association with posttransplant malignancies, Transplantation, 80, 1514, 10.1097/01.tp.0000181193.98026.3f Viguier, 2004, Foxp3 expressing CD4+ CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells, J Immunol, 173, 1444, 10.4049/jimmunol.173.2.1444 Bates, 2006, Quantification of regulatory T cells enables the identification of high risk breast cancer patients and those at risk of late relapse, J Clin Oncol, 24, 5373, 10.1200/JCO.2006.05.9584 Siewert, 2008, Experience-driven development: Effector/memory-like aE+Foxp3+ regulatory T cells originate from both naive T cells and naturally occurring naive-like regulatory T cells, J Immunol, 180, 146, 10.4049/jimmunol.180.1.146 Allan, 2007, Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production, Int Immunol, 19, 345, 10.1093/intimm/dxm014 Floess, 2007, Epigenetic control of the foxp3 locus in regulatory T cells, PLoS Biol, 5, e38, 10.1371/journal.pbio.0050038 Miller, 1996, The aging immune system: Primer and prospectus, Science, 273, 70, 10.1126/science.273.5271.70 McDonald, 2007, Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcome, Am J Transplant, 7, 1201, 10.1111/j.1600-6143.2007.01759.x Liyanage, 2002, Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma, J Immunol, 169, 2756, 10.4049/jimmunol.169.5.2756 Mizukami, 2008, Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer, Br J Cancer, 98, 148, 10.1038/sj.bjc.6604149 Martin, 2010, Human FOXP3 and cancer, Oncogene, 29, 4121, 10.1038/onc.2010.174 Hope, 2014, The immune phenotype may relate to cancer development in kidney transplant recipients, Kidney Int, 86, 175, 10.1038/ki.2013.538 Borgogna, 2014, Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients, Mod Pathol, 27, 1101, 10.1038/modpathol.2013.240 Akimova, 2012, Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients, Am J Transplant, 12, 3449, 10.1111/j.1600-6143.2012.04269.x